Bio-Techne (MIL:1TECH) Interest Expense: €-8 Mil (TTM As of Mar. 2026)

What is Bio-Techne Interest Expense?

Bio-Techne MIL:1TECH 60 Interest Expense is €-8 Mil as of Mar. 2026. GuruFocus rates MIL:1TECH with a GF Score™ of 60/100 and a GF Value™ of €77.08 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bio-Techne's interest expense for the three months ended in Mar. 2026 was € -2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bio-Techne's Operating Income for the three months ended in Mar. 2026 was € 65 Mil. Bio-Techne's Interest Expense for the three months ended in Mar. 2026 was € -2 Mil. Bio-Techne's Interest Coverage for the quarter that ended in Mar. 2026 was 31.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Techne (MIL:1TECH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Techne's Interest Expense for the three months ended in Mar. 2026 was €-2 Mil. Its Operating Income for the three months ended in Mar. 2026 was €65 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €239 Mil.

Bio-Techne's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	65.303	/	-2.078
	=	31.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bio-Techne Interest Expense Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Interest Expense can be seen below:

Bio-Techne Interest Expense Chart

Bio-Techne Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Interest Expense

Get a 7-Day Free Trial

-11.58

-10.70

-10.35

-14.62

-7.38

Bio-Techne Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-1.86	-1.89	-2.50	-1.85	-2.08

60GF Score

Bio-Techne Corp MIL:1TECH

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bio-Techne Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of €-8 Mil mean?

Bio-Techne (MIL:1TECH) has a Interest Expense of €-8 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Techne and its competitors.

Is Bio-Techne's Interest Expense too high?

Bio-Techne's current Interest Expense is €-8 Mil. Overall, Bio-Techne has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Bio-Techne's Interest Expense compare to ARWR and CYTK?

Bio-Techne's Interest Expense of €-8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Techne and its competitors. Bio-Techne's current Interest Expense is €-8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bio-Techne stock overvalued right now?

Based on GuruFocus' analysis, Bio-Techne (MIL:1TECH) is currently considered Modestly Undervalued. The stock's GF Value™ is €77.08, compared to a current price of €62.06 — trading 19.5% below its estimated fair value. The current Interest Expense is €-8 Mil. Bio-Techne's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Bio-Techne (MIL:1TECH), the current Interest Expense is €-8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MIL:1TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of €62.06 is trading 19.5% below its estimated GF Value™ of €77.08. GuruFocus considers Bio-Techne to be Modestly Undervalued.

Key valuation signals for MIL:1TECH:

Interest Expense: €-8 Mil
GF Value™: €77.08 vs. price of €62.06 (19.5% below fair value)
GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the MIL:1TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Industry Healthcare Biotechnology

Comparable Companies ARWR CYTK KRYS SMMT BMRN MDGL APGE NUVL AXSM CORT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges TECH:USA TE1:Germany T1CH34:Brazil

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

60GF Score

Get the complete analysis for MIL:1TECH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€62.06

Price

€77.08

GF Value

View MIL:1TECH Analysis

See Interest Expense data for all stocks →